No Data
No Data
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $33
Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $39
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
JMP Securities Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $43
Evolent Health Buy Rating Affirmed With Increased Price Target Amid Growth Prospects and M&A Speculation
Evolent Health (NYSE:EVH) Pulls Back 5.1% This Week, but Still Delivers Shareholders Incredible 33% CAGR Over 5 Years